Results
71,123 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 12 | Gemayel GeorgesDirector |  SUPNSUPERNUS PHARMACEUTICALS, INC.Other acquisition or disposition | J | — 27.3K sh | Nov 4, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 12 | Gemayel GeorgesDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 27.3K sh | Nov 4, 2026 |
| 12 | Gemayel GeorgesDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 6,293 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 1.26M sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Bhatt Padmanabh P.Sr. VP of IP, CSO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 2,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Barker BrianDirector |  ACUACME UNITED CORPOption exercise | M | $109K 5,000 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 40.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Coghlan John PhilipDirector |  LIFLife360, Inc.Open-market sale · 10b5-1 plan | SELL | $66K 1,433 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mitra SabyaschiGroup President |  EMREMERSON ELECTRIC COTax withholding | F | $79K 477 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 281.3K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Coghlan John PhilipDirector | LIFLife360, Inc. Open-market sale · 10b5-1 plan | SELL | $83K 1,841 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 250.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 20.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Bhatt Padmanabh P.Sr. VP of IP, CSO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 2,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,375 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 6,036 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Barlow CarroleeDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 7,296 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 17.5K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 205.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 200.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 |  Kurtz GeorgeDirector, PRESIDENT AND CEO |  CRWDCrowdStrike Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $3.48M 13.8K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hovnanian Alexander A.President |  HOVHOVNANIAN ENTERPRISES INCTax withholding | F | $81K 770 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Rubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 2,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Rubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 300.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Rubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 15.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Bhatt Padmanabh P.Sr. VP of IP, CSO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 18.6K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 331.7K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 8,252 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 958.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Barlow CarroleeDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 4,977 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Gemayel GeorgesDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 6,036 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 2,989 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 4,977 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 |  Ricks David ADirector, President, Chair, and CEO |  LLYELI LILLY & CoGift | G | — 23.5K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 12 | Gemayel GeorgesDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 2,989 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 100.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Comly Barbara J.EVP, GC & Corporate Secretary |  MIAXMIAMI INTERNATIONAL HOLDINGS, INC.Open-market sale · 10b5-1 plan | SELL | $819K 23.3K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 19.5K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 1,875 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Gemayel GeorgesDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 12.4K sh | Nov 4, 2026 traded Nov 2, 2026 |